Trials / Completed
CompletedNCT02547532
Microbioma in Sputa From COPD With Alpha-1 Antitrypsin Deficiency
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Fondazione Salvatore Maugeri · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In the context of the increasing evidence of the pathogenetic role of microbiome in COPD, our aim is to determine the total and specific bacterial and viral load in sputa from patients with COPD due to AATD and to correlate these findings with cellular, biochemical and immunological characteristics of sputa. These quantitative data obtained from sputum will be analyzed in the context of the clinical and physiological parameters of the patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | collection of sputum |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2015-09-11
- Last updated
- 2018-08-01
Source: ClinicalTrials.gov record NCT02547532. Inclusion in this directory is not an endorsement.